PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
09-Sep-2025 Servier acquires potential treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder Servier
09-Sep-2025 TRIMTECH Therapeutics establishes Scientific Advisory Board TRIMTECH Therapeutics
09-Sep-2025 NRG Therapeutics Announces Oversubscribed £50m ($67m) Series B Financing to Deliver Clinical Data in Parkinson’s and Proof of Concept in ALS/MND NRG Therapeutics
09-Sep-2025 Real-world evidence supports clinical effectiveness of neffy®/EURneffy® in U.S. patients experiencing anaphylaxis ALK
09-Sep-2025 Senzime welcomes new Japanese guidelines on neuromuscular monitoring Senzime
09-Sep-2025 Alchemab Therapeutics initiates Phase 1 clinical trial of ATLX-1282 and announces Series A financing extension Alchemab Therapeutics
09-Sep-2025 Results from BIG D-FOOT study using STIMULAN® when treating DFO to be presented at EBJIS 2025 Biocomposites
09-Sep-2025 Pheon Therapeutics Bolsters Board of Directors with Oncology R&D Expert Dr. Samuel Blackman Pheon Therapeutics
08-Sep-2025 Proscia Unveils Aperture, Making the Moment of Diagnosis the Gateway to Life-Saving Treatments for More Patients Proscia
08-Sep-2025 NRG Therapeutics Announces Oversubscribed £50m ($67m) Series B Financing to Deliver Clinical Data in Parkinson’s and Proof of Concept in ALS/MND NRG Therapeutics
08-Sep-2025 ProductLife Group Expands to Deliver Localized Expertise & Enhanced Client Support in Japan ProductLife Group
08-Sep-2025 Stanford University Secures NIH Grant to Advance tiakis Biotech´s Elafin (Tiprelestat) Through a U.S. Phase II Trial in Pulmonary Arterial Hypertension tiakis Biotech AG
04-Sep-2025 ProductLife Group Expands to Deliver Localized Expertise & Enhanced Client Support in Japan ProductLife Group
04-Sep-2025 Pistoia Alliance unveils agentic AI initiative and seeks industry funding to drive safe adoption Pistoia Alliance
04-Sep-2025 AC Immune Sharpens Pipeline Focus with Operational Efficiencies Extending Cash Runway AC Immune
04-Sep-2025 Onco3R Therapeutics Announces Approval of First Clinical Trial Application for Novel SIK3 inhibitor O3R-5671 in Autoimmune Diseases Onco3R Therapeutics
04-Sep-2025 PulseSight Therapeutics Provides New Insights into the Role of Iron and Transferrin in AMD, Supporting its PST-611 Vectorized Therapy for Dry AMD/Geographic Atrophy at EURETINA 2025 PulseSight Therapeutics
04-Sep-2025 Kuros Biosciences announces changes in the Board of Directors Kuros Biosciences
04-Sep-2025 NuCana to Present Data on NUC-7738’s Synergy with PD-1 Inhibitors at the ESMO Congress 2025 NuCana
04-Sep-2025 Health Economics Study on Ondine’s Steriwave® Selected for Oral Presentation at ICPIC 2025 in Geneva Ondine